Executive Appointments in Connection with the Establishment of NESIC Holdings
TOKYO, Jun 23, 2025 - (JCN Newswire) - - NEC Corporation (NEC; TSE: 6701) and NESIC Holdings, Ltd. today announced executive appointments that will become effective as of July 1, 2025.
NESIC Holdings, Ltd. is an intermediate holding company established as a wholly owned subsidiary of NEC. NESIC Holdings, Ltd. will take over all shares of NEC Networks & System Integration Corporation and NEC Nexsolutions, Ltd. owned by NEC as of July 1, 2025, and commence operations.
Under NESIC Holdings, Ltd., NEC Networks & System Integration Corporation and NEC Nexsolutions, Ltd. will integrate their business operations to establish a business structure capable of providing integrated IT and network solutions for digital transformation (DX), from consulting to system integration (SI), construction, and maintenance. This will enable both companies to expand their current business areas and target local governments and small and medium-sized enterprises throughout Japan, where demand for DX is set to grow significantly.
For the full press release, visit https://www.nec.com/en/press/202506/global_20250623_01.html.
About NEC Corporation
NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com.
Copyright 2025 JCN Newswire . All rights reserved.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NEC Corporation (6701:JP) (NIPNF) PT Raised to JPY5,400 at JPMorgan
- Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
- Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share